NEKTAR THERAPEUTICS |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.47 USD | +11.36% |
|
+8.46% | +161.06% |
Chart calendar Nektar Therapeutics
06b6ddfb4c3a11fb.DzeutdRst6FVulb0qKavp3Sp_EIDeib2KX7lL8QIBI4.O3WX5rU9h84n6ySf-uf-6BL7viw6D1SEXSedS_ZFN-xpbZvMgRTQyyPZEw~0cfc1d888f4c91b80b7a8da6c61d0bbe
Upcoming events on Nektar Therapeutics
Past events on Nektar Therapeutics
| 28/03/2024 17:30 | H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference |
| 05/03/2024 19:10 | TD Cowen Health Care Conference |
| 04/03/2024 22:00 | Q4 2023 Earnings Call |
| 04/03/2024 21:15 | Q4 2023 Earnings Release |
| 11/01/2024 01:15 | JPMorgan Healthcare Conference |
| 07/11/2023 22:00 | Q3 2023 Earnings Call |
| 07/11/2023 21:15 | Q3 2023 Earnings Release |
| 13/10/2023 13:30 | European Academy of Dermatology and Venereology Conference - Abstract #6685 |
| 10/10/2023 | European Academy of Dermatology and Venereology Conference - Abstract #6218 |
| 13/09/2023 16:00 | Investor & Analyst Meeting |
| 08/08/2023 22:00 | Q2 2023 Earnings Call |
| 08/08/2023 21:15 | Q2 2023 Earnings Release |
| 14/06/2023 21:20 | Goldman Sachs Global Healthcare Conference |
| 08/06/2023 22:00 | Annual General Meeting |
| 09/05/2023 22:00 | Q1 2023 Earnings Call |
| 09/05/2023 21:15 | Q1 2023 Earnings Release |
| 28/02/2023 22:15 | Q4 2022 Earnings Release |
| 23/02/2023 22:00 | REZPEG Phase 2 Study Results Call |
| 11/01/2023 16:15 | JP Morgan Healthcare Conference |
| 12/12/2022 13:30 | Investor Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 115 108 6.09% | 153 159 -3.97% | 102 102 -0.03% | 92,1 91,5 0.66% | 90,1 84,3 6.88% | 72,5 |
|
EBITDA Million USD | Released Forecast Spread | -427 -440 2.99% | -411 -430 4.52% | -432 -451 4.23% | -363 -398 8.74% | -256 -250 -2.46% | -122 |
|
EBIT Million USD | Released Forecast Spread | -440 -449 2.1% | -425 -432 1.5% | -446 -470 5.08% | -376 -401 6.13% | -264 -269 2.07% | -161 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -440 -449 2.05% | -444 -443 -0.3% | -523 -530 1.21% | -365 -401 9.01% | -276 -275 -0.57% | -168 |
|
Net income Million USD | Released Forecast Spread | -441 -447 1.33% | -444 -443 -0.42% | -524 -530 1.2% | -368 -403 8.56% | -276 -275 -0.53% | -168 |
|
EPS USD | Released Forecast Spread | -2,52 -2,52 0.07% | -2,49 -2,49 0.06% | -2,86 -2,90 1.53% | -1,97 -2,15 8.45% | -1,45 -1,45 -0.21% | -0,85 |
| Announcement Date | 27/02/20 | 25/02/21 | 28/02/22 | 28/02/23 | 04/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 25,0 25,2 -0.65% | 24,8 24,9 -0.26% | 21,6 22,7 -5.1% | 23,6 22,6 4.5% | 22,0 22,2 -0.86% | 21,6 19,4 11.16% | 20,5 21,8 -6.08% | 24,1 21,3 13.28% | 23,9 21,4 11.78% | 15,3 | 15,3 | 15,3 | 15,3 |
|
EBITDA Million USD | Released Forecast Spread | -109 -128 14.55% | -113 -138 18.24% | -149 -200 25.3% | -51,6 -75,0 31.17% | -49,3 -68,0 27.52% | -42,7 -53,0 19.42% | -31,9 -26,0 -22.53% | ||||||
|
EBIT Million USD | Released Forecast Spread | -113 -133 15.07% | -117 -125 6.46% | -153 -172 11.29% | -54,3 -73,6 26.26% | -52,5 -72,1 27.2% | -45,0 -39,0 -15.33% | -50,6 -45,1 -12.08% | -44,9 -33,8 -32.81% | -33,5 -39,2 14.6% | -38,9 | -38,9 | -39,1 | -40,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -146 -149 2.32% | -90,3 -135 32.98% | -159 -182 12.43% | -59,2 -84,6 29.98% | -56,5 -81,0 30.16% | -137 -45,5 -201.11% | -51,2 -58,6 12.73% | -45,9 -38,8 -18.34% | -42,1 -43,4 3.07% | -40,1 | -41,9 | -43,6 | -44,9 |
|
Net income Million USD | Released Forecast Spread | -146 -147 1.24% | -90,4 -129 30.16% | -159 -187 14.9% | -59,0 -86,0 31.36% | -59,7 -84,1 29.07% | -137 -48,0 -185.38% | -51,1 -55,5 7.93% | -45,8 -39,5 -15.95% | -42,1 -43,7 3.69% | -40,1 | -41,9 | -43,6 | -44,9 |
|
EPS USD | Released Forecast Spread | -0,79 -0,81 2.14% | -0,49 -0,70 29.63% | -0,85 -1,00 15.17% | -0,31 -0,46 32.2% | -0,32 -0,45 28.34% | -0,73 -0,26 -185.98% | -0,27 -0,28 4% | -0,24 -0,20 -20.86% | -0,22 -0,21 -3.51% | -0,20 | -0,20 | -0,20 | -0,20 |
| Announcement Date | 28/02/22 | 05/05/22 | 04/08/22 | 03/11/22 | 28/02/23 | 09/05/23 | 08/08/23 | 07/11/23 | 04/03/24 | - | - | - | - |
More events
Past sector events for Nektar Therapeutics
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NKTR Stock
- Calendar Nektar Therapeutics
